Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors Sabina SandigurskyAdam Mor Hot Topics (B Cronstein, Section Editor) 06 September 2018 Article: 65
A Practical Approach to the Use of Conventional Synthetic, Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for the Treatment of Inflammatory Arthritis in Patients with a History of Malignancy Peter K. K. WongHanish BaggaLaurel Young Rheumatoid Arthritis (L Moreland, Section Editor) 01 September 2018 Article: 64
Brief Report on the 10th Meeting of the European Forum on Antiphospholipid Antibodies Valérie EschwègeCécile M. YelnikDenis Wahl Invited Commentary 21 August 2018 Article: 63
Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant) Claudia Mendoza-PintoMario García-CarrascoRicard Cervera Antiphospholipid Syndrome (S Zuily, Section Editor) 20 August 2018 Article: 62
Rheumatic Manifestations of Haemoglobinopathies Michael Hughes Orphan Diseases (B Manger, Section Editor) 14 August 2018 Article: 61
Induction Therapy for Lupus Nephritis: the Highlights Isabelle AyoubJessica NelsonBrad H. Rovin Pediatric Rheumatology (S Ozen, Section Editor) 14 August 2018 Article: 60
Obstetric Anti-phospholipid Syndrome: State of the Art Maria Chiara GerardiMelissa Alexandre FernandesLaura Andreoli Antiphospholipid Syndrome (S Zuily, Section Editor) 13 August 2018 Article: 59
The History of Psoriatic Arthritis (PsA): From Moll and Wright to Pathway-Specific Therapy Luis R. Espinoza Psoriatic Arthritis (J Scher, Section Editor) 09 August 2018 Article: 58
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis Sizheng ZhaoLaura ChadwickRobert J. Moots Biosimilars (E Mysler, Section Editor) Open access 09 August 2018 Article: 57